Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study.

[1]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.

[2]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[3]  J. Hallas,et al.  Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012 , 2014, Clinical epidemiology.

[4]  J. Gilmer,et al.  Aspirin Use in Heart Failure: Is Low Dose Therapy Associated with Mortality and Morbidity Benefits in a Large Community Population? Bermingham Et Al: Low-dose Aspirin and Mortality in Heart Failure , 2022 .

[5]  P. Gurbel,et al.  Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. , 2014, JACC. Heart failure.

[6]  J. Cleland,et al.  Controversies in cardiovascular medicine Is aspirin useful in primary prevention ? , 2013 .

[7]  A. Tartaro,et al.  Magnetic resonance spectroscopy to detect functional improvement by adipose tissue-derived stromal cell transplantation in the ischemic hind limb in diabetic rats , 2013 .

[8]  K. Overvad,et al.  Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry , 2012, Scandinavian cardiovascular journal : SCJ.

[9]  Shunichi Homma,et al.  Warfarin and aspirin in patients with heart failure and sinus rhythm. , 2012, The New England journal of medicine.

[10]  J. Hallas,et al.  The Danish National Prescription Registry , 2011, Scandinavian journal of public health.

[11]  J. Nessler,et al.  Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism , 2010, Heart.

[12]  C. O'connor,et al.  Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial , 2009, Circulation.

[13]  L. Køber,et al.  Accuracy of a heart failure diagnosis in administrative registers , 2008, European journal of heart failure.

[14]  T. Truelsen,et al.  Validity of Stroke Diagnoses in a National Register of Patients , 2007, Neuroepidemiology.

[15]  S. Yusuf,et al.  Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.

[16]  G. Fonarow,et al.  Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.

[17]  P. Toutouzas,et al.  Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study , 2006, European journal of heart failure.

[18]  P A Poole-Wilson,et al.  The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. , 2004, American heart journal.

[19]  M. Yaron,et al.  Early and late effects of low-dose aspirin on renal function in elderly patients. , 2003, The American journal of medicine.

[20]  B. Brendorp,et al.  Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. , 2003, European heart journal.

[21]  M. Osler,et al.  The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. , 2003, Journal of clinical epidemiology.

[22]  Y. Loke,et al.  Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis , 2000, BMJ : British Medical Journal.

[23]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[24]  J. Cleland.  Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease. , 2002, Progress in cardiovascular diseases.